ID
46151
Descripción
Principal Investigator: Javed Khan, MD, National Institutes of Health, Bethesda, MD, USA MeSH: Rhabdomyosarcoma,Rhabdomyosarcoma, Alveolar,Rhabdomyosarcoma, Embryonal https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000720 Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood accounting for approximately 350 newly diagnosed cases yearly in the United States. With the development of multimodal chemotherapy regimens, relapse-free survival rates have improved to 70-80% in patients with localized disease albeit with significant toxicity. Unfortunately, despite aggressive treatment, patients with metastatic or recurrent disease continue to suffer from high mortality. Further characterization of the genetic events underlying this tumor type is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. In a collaborative effort between the National Cancer Institute, the Children's Oncology Group, and the Broad Institute, we use a combination of whole-genome and whole-exome sequencing to characterize the landscape of somatic alterations in 147 tumor/normal pairs.
Link
Palabras clave
Versiones (2)
- 14/12/22 14/12/22 - Simon Heim
- 29/1/25 29/1/25 - Akane Nishihara
Titular de derechos de autor
Javed Khan, MD, National Institutes of Health, Bethesda, MD, USA
Subido en
29 de enero de 2025
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000720 Genomic sequencing of Pediatric Rhabdomyosarcoma
Eligibility Criteria
- StudyEvent: dbGaP phs000720 Genomic sequencing of Pediatric Rhabdomyosarcoma
- Eligibility Criteria
- Subject ID, sex, and consent group of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, sample ID, and sample use variable of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, age at onset, and sex of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary tumor or metastasis, and sequencing center of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
Similar models
Eligibility Criteria
- StudyEvent: dbGaP phs000720 Genomic sequencing of Pediatric Rhabdomyosarcoma
- Eligibility Criteria
- Subject ID, sex, and consent group of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, sample ID, and sample use variable of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Subject ID, age at onset, and sex of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
- Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary tumor or metastasis, and sequencing center of participants with pediatric rhabdomyosarcoma and involved in the "Genomic sequencing of Pediatric Rhabdomyosarcoma" project.
C0680251 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0441833 (UMLS CUI [1,4])
C1516477 (UMLS CUI [1,5])
C1513882 (UMLS CUI [1,6])
C4764268 (UMLS CUI [1,7])
Sin comentarios